NICE Board Approves Landmark Changes To Increase Flexibility Of Drug Evaluation Methods And Processes In England
Industry Has Mixed Response To “Largest And Most Comprehensive Review”
• By Leela Barham
Assessing Whether New Medicines Are Value For Money: No Easy Balance • Source: Alamy 
